Active Pharmaceutical Ingredients Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Nov 2018| TMR1096A| Transparency

Report Highlights

Active Pharmaceutical Ingredients (API) Market - Overview

Biotech/biological APIs have witnessed constant technological evolution, owing to a shift from synthetic chemical APIs to biotech/biological APIs in the global active pharmaceutical ingredients market.

Rise in demand for new drugs at a low cost and entry of domestic and global companies in the APIs market have led to innovative product offerings with new and advanced techniques. Any substance or combination of substances used in a finished pharmaceutical product (FPP) is known as active pharmaceutical ingredients (API). A finished dose of any drug is a combination of active pharmaceutical ingredients and excipients. An excipient is an inactive substance in a drug dose.

High-potency active pharmaceutical ingredients (HPAPIs) and antibody-drug conjugates are recent innovations in the market and require a special manufacturing set up. Most of these drugs are used in oncology. A large number of patents for small molecule APIs are expected to expire in the next few years, with many drugs losing patent protection in 2018. This is estimates to unlock a significant market opportunity for generic drug manufacturers, resulting in augmented demand for APIs. Large pharmaceutical companies are scaling down their small molecule manufacturing facilities to focus on biologic drugs, thereby presenting greater opportunities for contract manufacturing companies, particularly in Asia.

A key trend of collaborations and acquisitions of related companies to increase geographic presence has been observed in the last few years. For instance, in July 2017, Sun Pharmaceutical Industries Ltd. entered into a long-term manufacturing agreement with Samsung BioLogics for the manufacture of Ilumya.

The global active pharmaceutical ingredients market has been broadly segmented based on manufacturer, APIs, drug, therapeutic, and region. In terms of manufacturer, the global market has been classified into in-house API manufacturing and API contract manufacturing. The in-house API manufacturing segment accounted for a key share of the global market, in terms of revenue, in 2017. The API contract manufacturing segment is estimated to expand at a significant growth rate during the forecast period. Consequently, the segment is estimated to gain significant market share by the end of 2026.

In terms of region, the global active pharmaceutical ingredients market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market and is projected to lose market share by the end of 2026. The market in North America is primarily driven by a rapid increase in the geriatric population, high adoption of new drugs, and rise in group dental practices in the U.S.. The market in Asia Pacific is projected to expand at a rapid pace during the forecast period. In Asia Pacific, Japan dominated the active pharmaceutical ingredients market, while the market in China is estimated to expand at a prominent CAGR during the forecast period. The report also profiles major players in the market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Major players operating in global active pharmaceutical ingredients market include Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Pfizer Inc., Boehringer Ingelheim International GmbH., Merck & Co., Inc., Novartis AG, F. Hoffmann-La Roche Ltd, and Bayer AG..

The global active pharmaceutical ingredients market has been segmented as given below:

Global Active Pharmaceutical Ingredients (API) Market, by Manufacturer
In-house API Manufacturing
API Contract Manufacturing

Global Active Pharmaceutical Ingredients (API) Market, by APIs
Synthetic Chemical API
Biotech/Biological API
Plant Extracts API
High-potency API
Classical Fermentation API

Global Active Pharmaceutical Ingredients (API) Market, by Drug
Branded or Innovative Prescription Drugs
Generic Prescription Drugs
over-the-counter (OTC) Drugs
Others

Global Active Pharmaceutical Ingredients (API) Market, by Therapeutic
Anti-infective Drugs
Metabolic Disorders Drugs
Cardiovascular Drugs
Oncology Drugs
Central Nervous System Drugs
Respiratory Diseases Drugs
Others

Global Active Pharmaceutical Ingredients (API) Market, by Region
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Rest of Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC
South Africa
Israel
Rest of Middle East & Africa

  • Table 1 : Global Active Pharmaceutical Ingredients (API) Market Value (US$ Mn) Forecast, by Type of Manufacturer, 2016–2026
  • Table 2 : Global Active Pharmaceutical Ingredients (API) Market Value (US$ Mn) Forecast, by Type of APIs, 2016–2026
  • Table 3 : Global Active Pharmaceutical Ingredients (API) Market Value (US$ Mn) Forecast, by Type of Drug, 2016–2026
  • Table 4 : Global Active Pharmaceutical Ingredients (API) Market Value (US$ Mn) Forecast, by Therapeutic, 2016–2026
  • Table 5 : Global Active Pharmaceutical Ingredients (API) Market Revenue (US$ Mn) Forecast, by Region, 2016–2026
  • Table 6 : Patent Expiry of Major Drugs in 2018
  • Table 7 : Patent Expiry of Major Drugs in 2019 & 2020
  • Table 8 : North America Active Pharmaceutical Ingredients (API) Market Value (US$ Mn) Forecast, by Type of Manufacturer, 2016–2026
  • Table 9 : North America Active Pharmaceutical Ingredients (API) Market Value (US$ Mn) Forecast, by Type of APIs, 2016–2026
  • Table 10 : North America Active Pharmaceutical Ingredients (API) Market Value (US$ Mn) Forecast, by Type of Drug, 2016–2026
  • Table 11 : North America Active Pharmaceutical Ingredients (API) Market Value (US$ Mn) Forecast, by Therapeutic, 2016–2026
  • Table 12 : North America Active Pharmaceutical Ingredients (API) Market Revenue (US$ Mn) Forecast, by Country 2016–2026
  • Table 13 : Europe Active Pharmaceutical Ingredients (API) Market Value (US$ Mn) Forecast, by Type of Manufacturer, 2016–2026
  • Table 14 : Europe Active Pharmaceutical Ingredients (API) Market Value (US$ Mn) Forecast, by Type of APIs, 2016–2026
  • Table 15 : Europe Active Pharmaceutical Ingredients (API) Market Value (US$ Mn) Forecast, by Type of Drug, 2016–2026
  • Table 16 : Europe Active Pharmaceutical Ingredients (API) Market Value (US$ Mn) Forecast, by Therapeutic, 2016–2026
  • Table 17 : Europe Active Pharmaceutical Ingredients (API) Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 18 : Asia Pacific Active Pharmaceutical Ingredients (API) Market Value (US$ Mn) Forecast, by Type of Manufacturers, 2016–2026
  • Table 19 : Asia Pacific Active Pharmaceutical Ingredients (API) Market Value (US$ Mn) Forecast, by Type of APIs, 2016–2026
  • Table 20 : Asia Pacific Active Pharmaceutical Ingredients (API) Market Value (US$ Mn) Forecast, by Type of Drug, 2016–2026
  • Table 21 : Asia Pacific Active Pharmaceutical Ingredients (API) Market Value (US$ Mn) Forecast, by Therapeutic, 2016–2026
  • Table 22 : Asia Pacific Active Pharmaceutical Ingredients (API) Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 23 : Latin America Active Pharmaceutical Ingredients (API) Market Value (US$ Mn) Forecast, by Type of Manufacturers, 2016–2026
  • Table 24 : Latin America Active Pharmaceutical Ingredients (API) Market Value (US$ Mn) Forecast, by Type of APIs, 2016–2026
  • Table 25 : Latin America Active Pharmaceutical Ingredients (API) Market Value (US$ Mn) Forecast, by Type of Drug, 2016–2026
  • Table 26 : Latin America Active Pharmaceutical Ingredients (API) Market Value (US$ Mn) Forecast, by Therapeutic, 2016–2026
  • Table 27 : Latin America Active Pharmaceutical Ingredients (API) Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 28 : Middle East & Africa Active Pharmaceutical Ingredients (API) Market Value (US$ Mn) Forecast, by Type of Manufacturers, 2016–2026
  • Table 29 : Middle East & Africa Active Pharmaceutical Ingredients (API) Market Value (US$ Mn) Forecast, by Type of APIs, 2016–2026
  • Table 30 : Middle East & Africa Active Pharmaceutical Ingredients (API) Market Value (US$ Mn) Forecast, by Type of Drug, 2016–2026
  • Table 31 : Middle East & Africa Active Pharmaceutical Ingredients (API) Market Value (US$ Mn) Forecast, by Therapeutic, 2016–2026
  • Table 32 : Middle East & Africa Active Pharmaceutical Ingredients (API) Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Figure 1 : Active Pharmaceutical Ingredients (API) Market Snapshot
  • Figure 2 : Executive Summary
  • Figure 3 : Global Active Pharmaceutical Ingredients (API) Market Value (US$ Mn), CAGR (%), and Market Share (%), by Region, 2018 and 2026
  • Figure 4 : Key Market Developments
  • Figure 5 : Global Active Pharmaceutical Ingredients (API) Market Value (US$ Mn) Forecast, 2016–2026
  • Figure 6 : Global Active Pharmaceutical Ingredients (API) Market Value Share, by Type of Manufacturers, 2018 and 2026
  • Figure 7 : Global Active Pharmaceutical Ingredients (API) Market Attractiveness, by Type of Manufacturers, 2018–2026
  • Figure 8 : Global Active Pharmaceutical Ingredients (API) Market Value Share, by Type of APIs, 2018 and 2026
  • Figure 9 : Global Active Pharmaceutical Ingredients (API) Market Attractiveness, by Type of APIs, 2018–2026
  • Figure 10 : Global Active Pharmaceutical Ingredients (API) Market Value Share, by Type of Drug, 2018 and 2026
  • Figure 11 : Global Active Pharmaceutical Ingredients (API) Market Attractiveness, by Type of Drug, 2018–2026
  • Figure 12 : Global Active Pharmaceutical Ingredients (API) Market Value Share, by Therapeutic, 2018 and 2026
  • Figure 13 : Global Active Pharmaceutical Ingredients (API) Market Attractiveness, by Therapeutic, 2018–2026
  • Figure 14 : Global Active Pharmaceutical Ingredients (API) Market Value Share, by Region, 2018 and 2026
  • Figure 15 : Global Active Pharmaceutical Ingredients (API) Market Attractiveness, by Region, 2018–2026
  • Figure 16 : North America Active Pharmaceutical Ingredients (API) Market Value (US$ Mn) Forecast, 2016–2026
  • Figure 17 : North America Active Pharmaceutical Ingredients (API) Market Value Share, by Type of Manufacturers, 2018 and 2026
  • Figure 18 : North America Active Pharmaceutical Ingredients (API) Market Attractiveness, by Type of Manufacturers, 2018–2026
  • Figure 19 : North America Active Pharmaceutical Ingredients (API) Market Value Share, by Type of APIs, 2018 and 2026
  • Figure 20 : North America Active Pharmaceutical Ingredients (API) Market Attractiveness, by Type of APIs, 2018–2026
  • Figure 21 : North America Active Pharmaceutical Ingredients (API) Market Value Share, by Type of Drug, 2018 and 2026
  • Figure 22 : North America Active Pharmaceutical Ingredients (API) Market Attractiveness, by Type of Drug, 2018–2026
  • Figure 23 : North America Active Pharmaceutical Ingredients (API) Market Value Share, by Therapeutic, 2018 and 2026
  • Figure 24 : North America Active Pharmaceutical Ingredients (API) Market Attractiveness, by Therapeutic, 2018–2026
  • Figure 25 : North America Active Pharmaceutical Ingredients (API) Market Value Share, by Country, 2018 and 2026
  • Figure 26 : North America Active Pharmaceutical Ingredients (API) Market Attractiveness, by Country, 2018–2026
  • Figure 27 : Europe Active Pharmaceutical Ingredients (API) Market Value (US$ Mn) Forecast, 2016–2026
  • Figure 28 : Europe Active Pharmaceutical Ingredients (API) Market Value Share, by Type of Manufacturers, 2018 and 2026
  • Figure 29 : Europe Active Pharmaceutical Ingredients (API) Market Attractiveness, by Type of Manufacturers, 2018–2026
  • Figure 30 : Europe Active Pharmaceutical Ingredients (API) Market Value Share, by Type of APIs, 2018 and 2026
  • Figure 31 : Europe Active Pharmaceutical Ingredients (API) Market Attractiveness, by Type of APIs, 2018–2026
  • Figure 32 : Europe Active Pharmaceutical Ingredients (API) Market Value Share, by Type of Drug, 2018 and 2026
  • Figure 33 : Europe Active Pharmaceutical Ingredients (API) Market Attractiveness, by Type of Drug, 2018–2026
  • Figure 34 : Europe Active Pharmaceutical Ingredients (API) Market Value Share, by Therapeutic, 2018 and 2026
  • Figure 35 : Europe Active Pharmaceutical Ingredients (API) Market Attractiveness, by Therapeutic, 2018–2026
  • Figure 36 : Europe Active Pharmaceutical Ingredients (API) Market Value Share, by Country/Sub-region, 2018 and 2026
  • Figure 37 : Europe Active Pharmaceutical Ingredients (API) Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 38 : Asia Pacific Active Pharmaceutical Ingredients (API) Market Value (US$ Mn) Forecast, 2016–2026
  • Figure 39 : Asia Pacific Active Pharmaceutical Ingredients (API) Market Value Share, by Type of Manufacturers, 2018 and 2026
  • Figure 40 : Asia Pacific Active Pharmaceutical Ingredients (API) Market Attractiveness, by Type of Manufacturers, 2018–2026
  • Figure 41 : Asia Pacific Active Pharmaceutical Ingredients (API) Market Value Share, by Type of APIs, 2018 and 2026
  • Figure 42 : Asia Pacific Active Pharmaceutical Ingredients (API) Market Attractiveness, by Type of APIs, 2018–2026
  • Figure 43 : Asia Pacific Active Pharmaceutical Ingredients (API) Market Value Share, by Type of Drug, 2018 and 2026
  • Figure 44 : Asia Pacific Active Pharmaceutical Ingredients (API) Market Attractiveness, by Type of Drug, 2018–2026
  • Figure 45 : Asia Pacific Active Pharmaceutical Ingredients (API) Market Value Share, by Therapeutic, 2018 and 2026
  • Figure 46 : Asia Pacific Active Pharmaceutical Ingredients (API) Market Attractiveness, by Therapeutic, 2018–2026
  • Figure 47 : Asia Pacific Active Pharmaceutical Ingredients (API) Market Value Share, by Country/Sub-region, 2018 and 2026
  • Figure 48 : Asia Pacific Active Pharmaceutical Ingredients (API) Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 49 : Latin America Active Pharmaceutical Ingredients (API) Market Value (US$ Mn) Forecast, 2016–2026
  • Figure 50 : Latin America Active Pharmaceutical Ingredients (API) Market Value Share, by Type of Manufacturers, 2018 and 2026
  • Figure 51 : Latin America Active Pharmaceutical Ingredients (API) Market Attractiveness, by Type of Manufacturers, 2018–2026
  • Figure 52 : Latin America Active Pharmaceutical Ingredients (API) Market Value Share, by Type of APIs, 2018 and 2026
  • Figure 53 : Latin America Active Pharmaceutical Ingredients (API) Market Attractiveness, by Type of APIs, 2018–2026
  • Figure 54 : Latin America Active Pharmaceutical Ingredients (API) Market Value Share, by Type of Drug, 2018 and 2026
  • Figure 55 : Latin America Active Pharmaceutical Ingredients (API) Market Attractiveness, by Type of Drug, 2018–2026
  • Figure 56 : Latin America Active Pharmaceutical Ingredients (API) Market Value Share, by Therapeutic, 2018 and 2026
  • Figure 57 : Latin America Active Pharmaceutical Ingredients (API) Market Attractiveness, by Therapeutic, 2018–2026
  • Figure 58 : Latin America Active Pharmaceutical Ingredients (API) Market Value Share, by Country/Sub-region, 2018 and 2026
  • Figure 59 : Latin America Active Pharmaceutical Ingredients (API) Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 60 : Middle East & Africa Active Pharmaceutical Ingredients (API) Market Value (US$ Mn) Forecast, 2016–2026
  • Figure 61 : Middle East & Africa Active Pharmaceutical Ingredients (API) Market Value Share, by Type of Manufacturers, 2018 and 2026
  • Figure 62 : Middle East & Africa Active Pharmaceutical Ingredients (API) Market Attractiveness, by Type of Manufacturers, 2018–2026
  • Figure 63 : Middle East & Africa Active Pharmaceutical Ingredients (API) Market Value Share, by Type of APIs, 2018 and 2026
  • Figure 64 : Middle East & Africa Active Pharmaceutical Ingredients (API) Market Attractiveness, by Type of APIs, 2018–2026
  • Figure 65 : Middle East & Africa Active Pharmaceutical Ingredients (API) Market Value Share, by Type of Drug, 2018 and 2026
  • Figure 66 : Middle East & Africa Active Pharmaceutical Ingredients (API) Market Attractiveness, by Type of Drug, 2018–2026
  • Figure 67 : Middle East & Africa Active Pharmaceutical Ingredients (API) Market Value Share, by Therapeutic, 2018 and 2026
  • Figure 68 : Middle East & Africa Active Pharmaceutical Ingredients (API) Market Attractiveness, by Therapeutic, 2018–2026
  • Figure 69 : Middle East & Africa Active Pharmaceutical Ingredients (API) Market Value Share, by Country/Sub-region, 2018 and 2026
  • Figure 70 : Middle East & Africa Active Pharmaceutical Ingredients (API) Market Attractiveness, by Country/Sub-region, 2018–2026

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report